A 72-year-old patient with TB is undergoing standard treatment in a health care facility.
Which ongoing assessment would the nurse complete?
Monitoring for the appearance of adverse reactions.
Monitoring the patient's vital signs every 24 hours.
Assessing the patient's history of contacts.
Use DOT to administer the drug to the patient.
The Correct Answer is A
Choice A rationale:
Monitoring for the appearance of adverse reactions is a crucial aspect of managing a patient with TB undergoing treatment. TB medications can have side effects, and early detection of adverse reactions is essential for timely intervention. Some common adverse effects of TB drugs include hepatotoxicity, peripheral neuropathy, and gastrointestinal disturbances. By closely monitoring the patient, the nurse can ensure prompt action if these side effects occur, improving the patient's overall care and safety.
Choice B rationale:
Monitoring the patient's vital signs every 24 hours may be part of standard nursing care, but when managing a patient with TB, the primary focus should be on monitoring for adverse reactions to the TB medications. Vital signs are important but not the most critical aspect of care in this specific situation.
Choice C rationale:
Assessing the patient's history of contacts is essential for identifying potential sources of TB transmission. However, it is more related to the initial assessment and diagnosis of TB rather than ongoing assessment during treatment. The primary focus during treatment is monitoring the patient's response to medication and any adverse reactions.
Choice D rationale:
Using Directly Observed Therapy (DOT) to administer TB drugs is a standard practice to ensure treatment adherence. However, ongoing assessment should focus on monitoring for adverse reactions and treatment effectiveness rather than the administration method, which is usually established at the beginning of treatment.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is A
Explanation
Choice A rationale:
Antiviral drugs are metabolized in the liver, and hepatic impairment can affect the metabolism and elimination of these drugs. Therefore, the nurse should administer antiviral therapy cautiously to clients with hepatic impairment to prevent potential drug toxicity. Hepatic impairment can alter the pharmacokinetics of antiviral drugs, leading to increased drug levels in the bloodstream.
Choice B rationale:
Renal impairment is not typically a contraindication for antiviral therapy. While some medications may require dose adjustments in patients with renal impairment, it is not a general concern for antiviral drugs. The primary organ responsible for the metabolism of antiviral drugs is the liver.
Choice C rationale:
Diabetes and hypertension are chronic medical conditions that are not directly related to the administration of antiviral therapy. These conditions do not significantly impact the pharmacokinetics or pharmacodynamics of antiviral drugs. Therefore, they are not primary factors to consider when administering antiviral therapy.
Choice D rationale:
Hypertension, like diabetes, is not directly related to the administration of antiviral therapy. Antiviral drugs primarily interact with the liver's metabolic pathways, and hypertension does not have a significant impact on drug metabolism.
Correct Answer is B
Explanation
Choice A rationale:
Nizatidine is not a proton pump inhibitor; it is an H2 receptor antagonist. It works by blocking the histamine H2 receptors in the stomach, reducing acid production. Proton pump inhibitors (PPIs) work differently by directly inhibiting the proton pump (H+/K+ ATPase) responsible for acid secretion in the stomach.
Choice B rationale:
Omeprazole is a proton pump inhibitor (PPI). PPIs are drugs that reduce gastric acid production by inhibiting the proton pump (H+/K+ ATPase) in the parietal cells of the stomach. This action is highly effective in treating conditions such as gastroesophageal reflux disease (GERD) and peptic ulcers.
Choice C rationale:
Sucralfate is not a proton pump inhibitor; it is a medication that forms a protective barrier over ulcers and erosions in the stomach and intestines. It does not directly affect acid production.
Choice D rationale:
Misoprostol is not a proton pump inhibitor; it is a synthetic prostaglandin E1 analog. It is primarily used to prevent gastric ulcers in individuals who are at high risk due to chronic nonsteroidal anti-inflammatory drug (NSAID) use. It has a protective effect on the gastric mucosa but does not inhibit acid secretion.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.